Autolus Therapeutics plc

AUTL

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001730463

SEC filings (opens in a new tab)

In the last 90 days, Autolus Therapeutics plc insiders filed 0 open-market purchases and 1 sale; 83 institutions reported holding it in 13F filings for Q2 2026, worth $212.0M in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Autolus Therapeutics plc changed between Q3 2021 and Q4 2021.

All holders in Q4 2021 All holders in Q3 2021

13F holders of AUTL: Q3 2021 compared with Q4 2021
Measure	Q3 2021	Q4 2021	Change
Holders	59	73	+14
Shares	25.1M	52.5M	+27.4M (+109.2%)
Value	$164.2M	$272.3M	+$108.0M (+65.8%)

New holders (24)

Institutions that held Autolus Therapeutics plc at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to AUTL in Q4 2021
Institution	Shares	Value	% of portfolio
Blackstone Group Inc.	17,985,611	$93.3M	0.23%
Syncona Portfolio Ltd	7,346,829	$38.1M	36.42%
Woodline Partners LP	937,961	$4.87M	0.07%
SG Americas Securities, LLC	250,822	$1.30M	0.01%
Harbor Capital Advisors, Inc.	211,319	$1.10M	0.40%
Alps Advisors Inc	84,382	$438.0K	0.00%
Resolute Capital Asset Partners LLC	65,115	$338.0K	0.22%
Caxton Associates LP	60,642	$315.0K	0.04%
Virtus ETF Advisers LLC	29,175	$151.0K	0.06%
Cubist Systematic Strategies, LLC	26,854	$139.0K	0.00%
Wealth Effects LLC	22,950	$119.0K	0.05%
Trexquant Investment LP	17,956	$93.0K	0.01%
Virtu Financial LLC	16,871	$88.0K	0.01%
Marshall Wace, LLP	16,178	$85.0K	0.00%
Susquehanna International Group, LLP	15,670	$81.0K	0.00%
Jane Street Group, LLC	13,352	$69.0K	0.00%
Blair William & Co	11,169	$58.0K	0.00%
Golden State Equity Partners	10,505	$55.0K	0.03%
Huntington National Bank	1,501	$8.00K	0.00%
Parallel Advisors, LLC	1,140	$6.00K	0.00%
Ulland Investment Advisors, LLC	1,000	$5.00K	0.00%
High Net Worth Advisory Group LLC	1,000	$5.00K	0.00%
Carmichael Hill & Associates, Inc.	508	$3.00K	0.00%
Cutler Group LP	100	$0	0.00%

Sold out (10)

Institutions that held Autolus Therapeutics plc at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of AUTL in Q4 2021
Institution	Shares, Q3 2021	Value, Q3 2021
Granahan Investment Management Inc	176,683	$1.16M
Jump Financial, LLC	65,900	$432.0K
Regency Capital Management Inc.	57,000	$373.0K
Brewin Dolphin Ltd	46,217	$302.7K
Acadian Asset Management LLC	31,289	$204.0K
New York State Common Retirement Fund	27,073	$177.0K
Brighton Jones LLC	17,560	$115.0K
ProShare Advisors LLC	12,192	$80.0K
Penserra Capital Management LLC	1,305	$8.00K
Barclays PLC	4	$0